Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Teladoc Health granted employment inducement equity awards to Michael Grasher in connection with his commencing employment as Chief Financial Officer, effective September 1, 2026. The package consists of restricted stock units covering 239,616 shares plus performance stock units with a target of 239,616 shares that can earn up to 479,232 shares. The PSUs vest based on 2026 adjusted EBITDA and Teladoc's actual revenue CAGR over 2026-2028.
Key figures
- Rsu shares
- 239616
- Psu metrics
- ["2026 adjusted EBITDA","2026-2028 revenue CAGR"]
- Psu max shares
- 479232
- Psu target shares
- 239616
- Grant effective date
- September 1, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.